| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3862479
[patent_doc_number] => 05795915
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Use of (x-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reutake and new compounds for this use'
[patent_app_type] => 1
[patent_app_number] => 8/649530
[patent_app_country] => US
[patent_app_date] => 1996-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4161
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795915.pdf
[firstpage_image] =>[orig_patent_app_number] => 649530
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/649530 | Use of (x-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reutake and new compounds for this use | May 16, 1996 | Issued |
Array
(
[id] => 3828444
[patent_doc_number] => 05760044
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Method for treating cocaine and amphetamine dependency'
[patent_app_type] => 1
[patent_app_number] => 8/648546
[patent_app_country] => US
[patent_app_date] => 1996-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8577
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/760/05760044.pdf
[firstpage_image] =>[orig_patent_app_number] => 648546
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/648546 | Method for treating cocaine and amphetamine dependency | May 15, 1996 | Issued |
Array
(
[id] => 3744611
[patent_doc_number] => 05801197
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-01
[patent_title] => 'Rotamase enzyme activity inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/645149
[patent_app_country] => US
[patent_app_date] => 1996-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5324
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/801/05801197.pdf
[firstpage_image] =>[orig_patent_app_number] => 645149
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/645149 | Rotamase enzyme activity inhibitors | May 12, 1996 | Issued |
Array
(
[id] => 3882751
[patent_doc_number] => 05798356
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-25
[patent_title] => 'Angiostatic compounds'
[patent_app_type] => 1
[patent_app_number] => 8/644018
[patent_app_country] => US
[patent_app_date] => 1996-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6981
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/798/05798356.pdf
[firstpage_image] =>[orig_patent_app_number] => 644018
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/644018 | Angiostatic compounds | May 8, 1996 | Issued |
| 08/647130 | ARYL-IMIDAZOLINES AND ARYL-IMIDAZOLES USEFUL AS ALPHA-2 ADRENERGIC AGONISTS WITHOUT CARDIOVASCULAR SIDE EFFECTS | May 8, 1996 | Abandoned |
Array
(
[id] => 4220737
[patent_doc_number] => 06040340
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/646518
[patent_app_country] => US
[patent_app_date] => 1996-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6002
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040340.pdf
[firstpage_image] =>[orig_patent_app_number] => 646518
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/646518 | Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors | May 6, 1996 | Issued |
Array
(
[id] => 3826334
[patent_doc_number] => 05731354
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Treatment for the inhibition of neuro-degenerative disease states'
[patent_app_type] => 1
[patent_app_number] => 8/643567
[patent_app_country] => US
[patent_app_date] => 1996-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4766
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/731/05731354.pdf
[firstpage_image] =>[orig_patent_app_number] => 643567
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/643567 | Treatment for the inhibition of neuro-degenerative disease states | May 5, 1996 | Issued |
Array
(
[id] => 3808958
[patent_doc_number] => 05854291
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Pain reliever and method of use'
[patent_app_type] => 1
[patent_app_number] => 8/635149
[patent_app_country] => US
[patent_app_date] => 1996-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2593
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/854/05854291.pdf
[firstpage_image] =>[orig_patent_app_number] => 635149
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/635149 | Pain reliever and method of use | Apr 22, 1996 | Issued |
Array
(
[id] => 3833935
[patent_doc_number] => 05814659
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Topical analgesic composition'
[patent_app_type] => 1
[patent_app_number] => 8/636440
[patent_app_country] => US
[patent_app_date] => 1996-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3686
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814659.pdf
[firstpage_image] =>[orig_patent_app_number] => 636440
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/636440 | Topical analgesic composition | Apr 22, 1996 | Issued |
Array
(
[id] => 3687036
[patent_doc_number] => 05663182
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-02
[patent_title] => 'Antipsychotic method'
[patent_app_type] => 1
[patent_app_number] => 8/633685
[patent_app_country] => US
[patent_app_date] => 1996-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20242
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 693
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/663/05663182.pdf
[firstpage_image] =>[orig_patent_app_number] => 633685
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/633685 | Antipsychotic method | Apr 16, 1996 | Issued |
Array
(
[id] => 3946205
[patent_doc_number] => 05998392
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Benzoyl peroxide flocculent materials and methods of their preparation'
[patent_app_type] => 1
[patent_app_number] => 8/630520
[patent_app_country] => US
[patent_app_date] => 1996-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1372
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998392.pdf
[firstpage_image] =>[orig_patent_app_number] => 630520
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/630520 | Benzoyl peroxide flocculent materials and methods of their preparation | Apr 9, 1996 | Issued |
Array
(
[id] => 3798959
[patent_doc_number] => 05827893
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-27
[patent_title] => 'Mechanical and pharmacological therapies to treat cardiac arrest'
[patent_app_type] => 1
[patent_app_number] => 8/625733
[patent_app_country] => US
[patent_app_date] => 1996-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4295
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/827/05827893.pdf
[firstpage_image] =>[orig_patent_app_number] => 625733
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/625733 | Mechanical and pharmacological therapies to treat cardiac arrest | Mar 28, 1996 | Issued |
Array
(
[id] => 3762779
[patent_doc_number] => 05852055
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof'
[patent_app_type] => 1
[patent_app_number] => 8/620815
[patent_app_country] => US
[patent_app_date] => 1996-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4000
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/852/05852055.pdf
[firstpage_image] =>[orig_patent_app_number] => 620815
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/620815 | Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof | Mar 24, 1996 | Issued |
| 08/632513 | ORAL DELIVERY OF NICOTINE TO TREAT PRIMARY SCLEROSING CHOLANGITIS | Mar 20, 1996 | Abandoned |
Array
(
[id] => 3984392
[patent_doc_number] => 05861434
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders'
[patent_app_type] => 1
[patent_app_number] => 8/612671
[patent_app_country] => US
[patent_app_date] => 1996-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2044
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861434.pdf
[firstpage_image] =>[orig_patent_app_number] => 612671
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/612671 | Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders | Mar 7, 1996 | Issued |
| 08/611528 | COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISORDERS | Mar 4, 1996 | Abandoned |
| 08/612908 | THERAPEUTIC COMPOSITION FOR DRUG DEPENDENCE | Feb 27, 1996 | Abandoned |
Array
(
[id] => 4036034
[patent_doc_number] => 05856313
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Natural carob fiber and method of using same'
[patent_app_type] => 1
[patent_app_number] => 8/604367
[patent_app_country] => US
[patent_app_date] => 1996-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2261
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856313.pdf
[firstpage_image] =>[orig_patent_app_number] => 604367
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/604367 | Natural carob fiber and method of using same | Feb 20, 1996 | Issued |
Array
(
[id] => 3826053
[patent_doc_number] => 05731336
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Method for treating multiple sclerosis'
[patent_app_type] => 1
[patent_app_number] => 8/603358
[patent_app_country] => US
[patent_app_date] => 1996-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21581
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 396
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/731/05731336.pdf
[firstpage_image] =>[orig_patent_app_number] => 603358
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/603358 | Method for treating multiple sclerosis | Feb 19, 1996 | Issued |
| 08/591568 | USE OF PHENOLS AND PHENOL DERIVATIVES AS PHARMACEUTICAL AGENTS WITH A FIBRINOGEN-LOWERING ACTION | Feb 12, 1996 | Abandoned |